content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001976146</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001720893</issuerCik>
        <issuerName>BioXcel Therapeutics, Inc.</issuerName>
        <secFileNumber>001-38410</secFileNumber>
        <issuerAddress>
          <com:street1>555 LONG WHARF DRIVE</com:street1>
          <com:city>NEW HAVEN</com:city>
          <com:stateOrCountry>CT</com:stateOrCountry>
          <com:zipCode>06511</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>203-643-8060</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Peter Mueller 2018 Irrevocable Family Trust</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>affilaite</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>common</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>cowen and company llc</name>
          <address>
            <com:street1>599 lexington ave, 27th floor</com:street1>
            <com:city>new york</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10022</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>112802</noOfUnitsSold>
        <aggregateMarketValue>338406.00</aggregateMarketValue>
        <noOfUnitsOutstanding>29270000</noOfUnitsOutstanding>
        <approxSaleDate>09/20/2023</approxSaleDate>
        <securitiesExchangeName>nasdaq</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>coomon</securitiesClassTitle>
        <acquiredDate>12/07/2018</acquiredDate>
        <natureOfAcquisitionTransaction>purchased in public market</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>BioXcel Therapeuctics</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>22802</amountOfSecuritiesAcquired>
        <paymentDate>12/07/2018</paymentDate>
        <natureOfPayment>purchased in public market</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>common</securitiesClassTitle>
        <acquiredDate>06/21/2018</acquiredDate>
        <natureOfAcquisitionTransaction>restricted stock units</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Dr.Peter Mueller</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>Y</isGiftTransaction>
        <donarAcquiredDate>01/03/2018</donarAcquiredDate>
        <amountOfSecuritiesAcquired>90000</amountOfSecuritiesAcquired>
        <paymentDate>06/21/2018</paymentDate>
        <natureOfPayment>gift</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>09/20/2023</noticeDate>
        <planAdoptionDates>
          <planAdoptionDate>03/21/2023</planAdoptionDate>
        </planAdoptionDates>
        <signature>/s/ Ulrike Mueller</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3499}]
text: 144
  0001976146
  XXXXXXXX
  LIVE
  0001720893
  BioXcel Therapeutics, Inc.
  001-38410
  555 LONG WHARF DRIVE
  NEW HAVEN
  CT
  06511
  203-643-8060
  Peter Mueller 2018 Irrevocable Family Trust
  affilaite
  common
  cowen and company llc
  599 lexington ave, 27th floor
  new york
  NY
  10022
  112802
  338406.00
  29270000
  09/20/2023
  nasdaq
  coomon
  12/07/2018
  purchased in public market
  BioXcel Therapeuctics
  N
  22802
  12/07/2018
  purchased in public market
  common
  06/21/2018
  restricted stock units
  Dr.Peter Mueller
  Y
  01/03/2018
  90000
  06/21/2018
  gift
  Y
  09/20/2023
  03/21/2023
  /s/ Ulrike Mueller